Why Your Berberine Failed: RevGenetics Unveils the Absorption Gap Solution
illi News/10328838

MIAMI - illiNews -- RevGenetics is disrupting the metabolic support market today with the commercial launch of DiBerberine 300x, an advanced enteric-coated dihydroberberine (DHB) supplement. By directly addressing the industry-wide "berberine absorption gap," RevGenetics exposes a flaw found in nearly every major competing brand: the failure to protect the active compound from stomach acid degradation and P-glycoprotein (P-gp) efflux pumps.

"The question we kept asking was: why is the supplement industry selling a mechanism - AMPK activation - with a delivery system that undermines the mechanism?" said RevGenetics founder Anthony Loera. "Most every major brand in the berberine category is selling a standard vegetarian capsule with berberine. Nobody in the supplement industry was solving them in a single product."

More on illi News

• Various Measures Introduced to and Approved by the Chicago City Council
• Chicago: Mayor Brandon Johnson Applauds Passage of Ald. Fuentes Led Measure Empowering COPA to Investigate Alleged Welcoming City Violations
• Chicago: Mayor Brandon Johnson, CFD Commissioner Nance-Holt Mourn the Passing of Firefighter-EMT Michael Altman
• Jackets for Jobs Hosts Smart & Sexy® Day Detroit for Women's History Month
• Klincher Live at Pop's Nightclub Brings High-Energy Rock Show to Sauget Illinois

Unlike standard formulas, The DiBerberine 300x Triple-Action Protocol sets a new standard by combining:

• Enteric Capsule Technology: Borrowing from pharmaceutical methods, this acid-resistant capsule bypasses the stomach without dissolving, preventing DHB from reverting to standard berberine HCl and ensuring release in the small intestine.
• DiBerberine™ Proprietary Blend (500mg per capsule): This leverages the profound pharmacokinetic advantage of DHB. A 2022 study showed a 100mg dose yielded ~6.7x greater plasma exposure than 500mg of standard berberine HCl.
• RGBooster1™: A patent-pending (U.S. App. No. 63/837,080) flavonoid complex. Internal assays demonstrate our Sophora japonica extract is up to 300x more potent than piperine at modulating the P-gp active transport mechanism that expels compounds from intestinal cells.

"Enteric coating isn't new technology," Loera stated. "Applying that technology to DHB was the obvious move. It just hadn't been done in a commercially available formula."

More on illi News

• Jeron Electronic Systems, Inc. to Showcase Area of Rescue Pro-Alert™ 480 at ISC West 2026, Booth #6130
• A Year in Love by Michael G. D'Aversa Offers Daily Celebrations of Romance and Devotion
• Mayor Brandon Johnson and Chicago City Council Honor, Celebrate, And Memorialize the Life and Legacy of the Rev. Jesse Jackson, Extend Condolences to the Jackson Family
• Tint Academy Training in Dallas Texas: Learn Window Tint & PPF Installation
• $IBG accelerates toward transformative merger with BlockFuel as $6 million raise fuels dual-industry growth strategy: N A S D A Q: IBG

Manufactured in the USA in a cGMP-certified, third-party tested facility, DiBerberine 300x is now available at revgenetics.com. A 30-day supply (30 enteric capsules) is priced at $44.95.

Health and wellness influencers, practitioners, and marketers interested in partnering with RevGenetics for this launch can access the affiliate program at getlink.revgenetics.com.